Janka Held‐Feindt

5.9k citations

115 papers · 4.7k indexed · h-index 41

Impact in

Genetics top 1%
- Glioma Diagnosis and Treatment
Immunology top 2%
- Immune cells in cancer
- Immunotherapy and Immune Responses

Papers in

Genetics 25
- Glioma Diagnosis and Treatment 24
Developmental Neuroscience 7

Co-authors: Rolf Mentlein H. Maximilian Mehdorn Kirsten Hattermann Ralph Lucius Friederike Knerlich‐Lukoschus Andreas M. Stark Dieter Kabelitz Michael Synowitz
Journals: Neurological Research (5 papers)Journal of Neurochemistry (5 papers)Journal of Neuro-Oncology (4 papers)International Journal of Cancer (4 papers)International Journal of Molecular Sciences (4 papers)
Partner nations: Germany United States China

In The Last Decade

Janka Held‐Feindt

114 papers receiving 4.6k citations

Peers

Countries citing papers authored by Janka Held‐Feindt

Since Specialization

Citations

This map shows the geographic impact of Janka Held‐Feindt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janka Held‐Feindt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janka Held‐Feindt more than expected).

Fields of papers citing papers by Janka Held‐Feindt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janka Held‐Feindt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janka Held‐Feindt. The network helps show where Janka Held‐Feindt may publish in the future.

Co-authors

The 25 scholars most cited alongside Janka Held‐Feindt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Janka Held‐Feindt Line = papers co-authored together Janka Held‐Feindt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Establishment of a Rodent Glioblastoma Partial Resection Model for Chemotherapy by Local Drug Carriers—Sharing Experience Biomedicines ·Carolin Kubelt, Dana Hellmold, Eva Peschke, Margarethe Hauck, Olga Will, Fabian Schütt, Ralph Lucius, Rainer Adelung, Regina Scherließ, Jan‐Bernd Hövener, Olav Jansen, Michael Synowitz, Janka Held‐Feindt	2023	1
2	Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells International Journal of Molecular Sciences ·Dana Hellmold, Carolin Kubelt, Tina Daunke, Silje Beckinger, Ottmar Janßen, Margarethe Hauck, Fabian Schütt, Rainer Adelung, Ralph Lucius, Jochen Haag, Susanne Sebens, Michael Synowitz, Janka Held‐Feindt	2023	1
3	Nitrogen-15 dynamic nuclear polarization of nicotinamide derivatives in biocompatible solutions Science Advances ·Josh P. Peters, Arne Brahms, Vivian Janicaud, Maria Anikeeva, Eva Peschke, Frowin Ellermann, Arianna Ferrari, Dana Hellmold, Janka Held‐Feindt, Na-mi Kim, Johannes Meiser, Konrad Aden, Rainer Herges, Jan‐Bernd Hövener, Andrey N. Pravdivtsev	2023	10
4	Insights into Gene Regulation under Temozolomide-Promoted Cellular Dormancy and Its Connection to Stemness in Human Glioblastoma Cells ·Carolin Kubelt, Dana Hellmold, Daniela Esser, Hajrullah Ahmeti, Michael Synowitz, Janka Held‐Feindt	2023	2
5	Localized Drug Delivery Systems in High‐Grade Glioma Therapy—From Construction to Application Advanced Therapeutics ·Margarethe Hauck, Dana Hellmold, Carolin Kubelt, Michael Synowitz, Rainer Adelung, Fabian Schütt, Janka Held‐Feindt	2022	13
6	AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy SHILAP Revista de lepidopterología ·Flak DK, Vivian Adamski, G Nowaczyk, Kosma Szutkowski, Michael Synowitz, Stefan Jurga, Janka Held‐Feindt	2020	2
7	Macroscopic Silicone Microchannel Matrix for Tailored Drug Release and Localized Glioblastoma Therapy ACS Biomaterials Science & Engineering ·Florian Rasch, Christina Schmitt, Lena M. Saure, Rieke Meyer, Vivian Adamski, Duygu Dengiz, Regina Scherließ, Ralph Lucius, Michael Synowitz, Yogendra Kumar Mishra, Kirsten Hattermann, Rainer Adelung, Janka Held‐Feindt, Fabian Schütt	2020	12
8	Expression Patterns of Hypoxia-Inducible Factors, Proinflammatory, and Neuroprotective Cytokines in Neuroepithelial Tissues of Lumbar Spinal Lipomas–A Pilot Study World Neurosurgery ·Gesa Cohrs, Bea Drucks, Michael Synowitz, Janka Held‐Feindt, Friederike Knerlich‐Lukoschus	2020	3
9	Establishment of a glioblastoma in vitro (in)complete resection dual co-culture model suitable for drug testing Annals of Anatomy - Anatomischer Anzeiger ·Christina Schmitt, Vivian Adamski, Florian Rasch, Rainer Adelung, Ralph Lucius, Michael Synowitz, Kirsten Hattermann, Janka Held‐Feindt	2019	12
10	Expression profiles of pro-inflammatory and pro-apoptotic mediators in secondary tethered cord syndrome after myelomeningocele repair surgery Child s Nervous System ·Gesa Cohrs, Bea Drucks, Jan-Philip Sürie, Christian Vokuhl, Michael Synowitz, Janka Held‐Feindt, Friederike Knerlich‐Lukoschus	2018	9
11	M1 and M2: there is no “good” and “bad”—How macrophages promote malignancy-associated features in tumorigenesis OncoImmunology ·Ole Helm, Janka Held‐Feindt, H. Schäfer, Susanne Sebens	2014	33
12	Inositol–Trisphosphate Reduces Alveolar Apoptosis and Pulmonary Edema in Neonatal Lung Injury American Journal of Respiratory Cell and Molecular Biology ·Stefanie Preuß, Sabrina Stadelmann, Friede D. Omam, Julia Scheiermann, Supandi Winoto‐Morbach, Philipp von Bismarck, Friederike Knerlich‐Lukoschus, Dennis Lex, Sabine Adam‐Klages, Daniela Wesch, Janka Held‐Feindt, Stefan Uhlig, Stefan Schütze, Martín Krause	2012	13
13	The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects Cancer Research ·Kirsten Hattermann, Janka Held‐Feindt, Ralph Lucius, Susanne Sebens Müerköster, Mark E.T. Penfold, Thomas J. Schall, Rolf Mentlein	2010	239
14	The Generation of Programmable Cells of Monocytic Origin Involves Partial Repression of Monocyte/Macrophage Markers and Reactivation of Pluripotency Genes Stem Cells and Development ·Hendrik Ungefroren, Stephanie Groth, Ayman Hyder, NIELS BECH THOMSEN, Hebke Hinz, Norbert Reiling, Evelin Grage‐Griebenow, Janka Held‐Feindt, Maren Schulze, Andreas K. Nüssler, Fred Fändrich	2010	16
15	Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner Journal of Neuroscience Methods ·Stephan Ulmer, Matthias Reeh, Joerg Krause, Thomas Herdegen, Janka Held‐Feindt, Olav Jansen, Axel Rohr	2008	14
16	Expression of stem cell markers in human astrocytomas of different WHO grades Journal of Neuro-Oncology ·Yue-Hui Ma, Rolf Mentlein, Friederike Knerlich‐Lukoschus, Marie‐Luise Kruse, H. Maximilian Mehdorn, Janka Held‐Feindt	2007	145
17	Functional Significance of Vascular Endothelial Growth Factor Receptor Expression on Human Glioma Cells Journal of Neuro-Oncology ·Rolf Mentlein, Frauke Forstreuter, H. Maximilian Mehdorn, Janka Held‐Feindt	2004	40
18	Molecular biologic and scintigraphic analyses of somatostatin receptor-negative meningiomas. PubMed ·Christian Meewes, K. H. Bohuslavizki, Brigitte Krisch, Janka Held‐Feindt, E. Henze, M. Clausen	2001	25
19	Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells International Journal of Cancer ·Rolf Mentlein, Olaf Eichler, Frauke Forstreuter, Janka Held‐Feindt	2001	90
20	Catecholamines and lipopolysaccharide synergistically induce the release of interleukin-6 from thymic epithelial cells Journal of Neuroimmunology ·Birte von Patay, Harald Loppnow, Janka Held‐Feindt, Bodo Kurz, Rolf Mentlein	1998	41

About Janka Held‐Feindt

Janka Held‐Feindt is a scholar working on Genetics, Developmental Neuroscience, Oncology, Immunology and Cancer Research, having authored 115 papers that have together received 4.7k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (24 papers), Chemokine receptors and signaling (15 papers), Spinal Cord Injury Research (10 papers), Immunotherapy and Immune Responses (9 papers), interferon and immune responses (9 papers), Receptor Mechanisms and Signaling (8 papers), Cancer Cells and Metastasis (8 papers) and Nerve injury and regeneration (7 papers). The work is most often cited by research in Genetics (796 citations), Immunology (1.3k citations), Oncology (1.5k citations), Cancer Research (753 citations) and Neurology (377 citations). Janka Held‐Feindt has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Rolf Mentlein, H. Maximilian Mehdorn, Kirsten Hattermann, Ralph Lucius, Friederike Knerlich‐Lukoschus, Andreas M. Stark, Dieter Kabelitz, Michael Synowitz, Susanne Sebens and Brigitte Krisch. Their work appears in journals such as Neurological Research, Journal of Neurochemistry, Journal of Neuro-Oncology, International Journal of Cancer and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact